An adviser to Europe’s highest court rebuked their actions in blocking U.S. gene sequencing company Illumina’s $7.1 billion bid for Grail. The adviser’s opinion, if endorsed by judges, could impact the scrutiny of other merger deals, including one involving U.S. chipmaker Qualcomm, where innovation concerns loom large.
The European Commission’s intervention in the Illumina-Grail deal, utilizing a rarely employed power under Article 22, attracted controversy as it fell below the EU merger revenue threshold. Despite this, the Commission asserted its authority following requests from multiple EU member states. Subsequently, the Commission vetoed the transaction and instructed Illumina to reverse the completed deal pending regulatory approval, reported Reuters.
Challenges ensued, with Illumina contesting the Commission’s decision on various grounds. A lower tribunal initially sided with the EU competition enforcer. However, Advocate General Nicholas Emiliou of the Court of Justice of the European Union (CJEU) criticized the General Court’s judgment, arguing that it had misinterpreted Article 22. Emiliou recommended overturning the General Court’s decision and annulling the Commission’s rulings on member states’ review requests.
Related: EU Blocks Illumina’s Deal To Buy Grail On Antitrust Grounds
The case has broader implications, particularly regarding the Commission’s approach to assessing mergers with innovation implications. The outcome could reshape the regulatory landscape for future deals, potentially altering the dynamics of cross-border mergers and acquisitions within the EU.
The European Commission’s role in regulating such transactions has faced increasing scrutiny, particularly concerning its handling of deals involving non-EU entities. The latest development underscores the need for clearer guidelines and more precise delineation of the Commission’s powers to ensure a fair and transparent regulatory environment conducive to innovation and competition.
As the CJEU deliberates on Emiliou’s recommendations, stakeholders await eagerly to see whether his critique will reshape the EU’s antitrust regime and impact future merger assessments.
Source: Reuters
Featured News
FTC Sues to Block Tempur Sealy’s $4.3 Billion Acquisition of Mattress Firm
Oct 24, 2024 by
CPI
Mexican Watchdog Proposes Fintech Reforms to Boost Financial Inclusion
Oct 24, 2024 by
CPI
AMA and ISMS File Antitrust Lawsuit Against MultiPlan Over Alleged Price-Fixing Scheme
Oct 24, 2024 by
CPI
Biden Administration Announces New AI Strategy to Boost National Security
Oct 24, 2024 by
CPI
Google Agrees to Provide AI-Related Documents in Monopoly Case
Oct 24, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Chevron
Oct 24, 2024 by
CPI
A Quartet of Decisions That Cripple Agencies
Oct 24, 2024 by
Richard J. Pierce
Goodbye, Chevron: Rediscovering the Virtues of an Independent Judiciary
Oct 24, 2024 by
Alexander Volokh
A New Era of Deference: From Chevron to Loper Bright
Oct 24, 2024 by
Daniel E. Walters
Loper Bright and Antitrust: Limited Impact on Enforcement, but a Clear Constraint on FTC Rulemaking
Oct 24, 2024 by
David Kully, Lynn Calkins & Kenneth Racowski